Patoloxía Molecular das Doenzas Raras
PatMol-DR
![Foto de Patoloxía Molecular das Doenzas Raras](/img/grupo.png)
![Foto de Massachusetts General Hospital](/img/noimage_org.png)
Massachusetts General Hospital
Boston, Estados UnidosPublicacións en colaboración con investigadores/as de Massachusetts General Hospital (5)
2021
-
Empagliflozin in heart failure with a preserved ejection fraction
New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461
2020
-
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial
European Journal of Heart Failure, Vol. 22, Núm. 12, pp. 2383-2392
-
α-Synuclein strains target distinct brain regions and cell types
Nature Neuroscience, Vol. 23, Núm. 1, pp. 21-31
2016
-
The diagnosis and management of lipodystrophy syndromes: A multi-society practice guideline
Journal of Clinical Endocrinology and Metabolism, Vol. 101, Núm. 12, pp. 4500-4511
2015
-
Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: Data from ROCKET AF
Journal of the American Heart Association, Vol. 5, Núm. 3